Amplifying mKRAS-Specific T cell Immunity for Treatment of MRD+ Pancreatic Cancer
- Targeting vaccine immunotherapy to lymph nodes with the AMP technology
- Development of ELI-002, an off-the-shelf therapeutic vaccine targeting mKRAS
- Clinical updates from AMPLIFY-201 and AMPLIFY-7P Phase 1/2 Trials